Arkolith/Insider Trading/FMTX/Form 4

Bishop John E

SVP, Chief Technology OfficerForma Therapeutics Holdings, Inc. (FMTX) · full profile →Form 4 · filed Oct 14, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 14, 2022Tender(U)48K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 14, 2022Disposed to issuer(D)67K——0
Oct 14, 2022Disposed to issuer(D)39K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-033652) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML